Spinocerebellar ataxia type 2 (SCA2) presenting with ophthalmoplegia and developmental delay in infancy

被引:29
作者
Moretti, P
Blazo, M
Garcia, L
Armstrong, D
Lewis, RA
Roa, B
Scaglia, F
机构
[1] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[2] UT Hlth Sci, Dept Pediat, San Antonio, TX USA
[3] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA
关键词
spinocerebellar ataxia; SCA2; childhood-onset ataxia; CAG repeat; triplet repeat expansion;
D O I
10.1002/ajmg.a.20428
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
An 11-year-old boy was evaluated for progressive ataxia, cognitive deterioration, and ophthalmoplegia. The child initially presented with abnormal eye movements at the age of 2 months and was noted to have developmental delay at 6 months. At the age of 7 years, he developed ataxia and. cognitive impairment, and subsequently manifested dysphagia and incontinence. The pertinent family history included gait difficulty in the paternal grandmother. At the age of 11, his general physical examination was normal. On neurological examination, he had bilateral external ophthalmoplegia, ataxic dysarthria, dysmetria and tremor in the upper extremities, and marked gait ataxia. An ophthalmological evaluation showed no evidence of pigmentary retinopathy. Brain MRI demonstrated cerebellar, brainstem, and cerebral atrophy. An ataxia panel showed 62 repeats in one allele of the SCA2 gene. Most cases of spinocerebellar ataxia type 2 (SCA2) present between 2:0 years and 40 years, and affected individuals typically have between 34 and 57 CAG repeats. Neonatal cases of SCA2 have been reported in individuals with over 200 CAG repeats. Childhood SCA2 has been reported previously in two patients but not described clinically. This case broadens the spectrum of the clinical features of infantile-onset SCA2 and highlights the importance of considering this diagnosis in infants and children. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:392 / 396
页数:5
相关论文
共 26 条
  • [21] SCA2 trinucleotide expansion in German SCA patients
    Riess, O
    Laccone, FA
    Gispert, S
    Schols, L
    Zuhlke, C
    Vieira-Saecker, AMM
    Herlt, S
    Wessel, K
    Epplen, JT
    Weber, BHF
    Kreuz, F
    Chahrokh-Zadeh, S
    Meindl, A
    Lunkes, A
    Aguiar, J
    Macek, M
    Krebsova, A
    Macek, M
    Burk, K
    Tinschert, S
    Schreyer, I
    Pulst, SM
    Auburger, G
    [J]. NEUROGENETICS, 1997, 1 (01) : 59 - 64
  • [22] Spinocerebellar ataxia type 2 (Sca2) associated with retinal pigmentary degeneration
    Rufa, A
    Dotti, MT
    Galli, L
    Orrico, A
    Sicurelli, F
    Federico, A
    [J]. EUROPEAN NEUROLOGY, 2002, 47 (02) : 128 - 129
  • [23] Neuronal degeneration and mitochondrial dysfunction
    Schon, EA
    Manfredi, G
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (03) : 303 - 312
  • [24] Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds
    Tang, BS
    Liu, CY
    Shen, L
    Dai, HP
    Pan, Q
    Jing, LJ
    Shan, QY
    Xia, JH
    [J]. ARCHIVES OF NEUROLOGY, 2000, 57 (04) : 540 - 544
  • [25] A clinicogenetic analysis of six Indian spinocerebellar ataxia (SCA2) pedigrees - The significance of slow saccades in diagnosis
    Wadia, N
    Pang, J
    Desai, J
    Mankodi, A
    Desai, M
    Chamberlain, S
    [J]. BRAIN, 1998, 121 : 2341 - 2355
  • [26] YOO SY, 2002, NEUROMUSCULAR DISORD, P1165